4ARONOV D M.Statins:therapeutic cascade of their effects[J].Kardiologiia(俄文),2004,44(10):85-94. 被引量：1
5STEIN E.The lower the better? reviewing the evidence for more aggressive cholesterol reduction and goal attainment[J].Atheroscler Suppl,2002,2(4):19-23. 被引量：1
6GUPTA S.Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment ?[J] Int J Cardiol,2004,96(2):131-139. 被引量：1
7SCHUSTER H.Rosuvastatin--a highly effective new 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitor:review of clinical trial data at 10-40 mg doses in dyslipidemic patients[J].Cardiology,2003,99(3):126-139. 被引量：1
8OLSSON A G.A new statin:a new standard[J].Clin Cardiol,2001,24(8 Suppl):Ⅲ18-Ⅲ23. 被引量：1
9BALBISI E A.Management of hyperlipidemia:new LDL-C targets for persons at high-risk for cardiovascular events[J].Med Sci Monit,2006,12(2):RA34-RA39. 被引量：1
1SCHWARTZ G G,OLSSON A G,EZEKOWITZ M D,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial[J].JAMA,2001,285 (13):1711-1718. 被引量：1
2CHALASANI N,ALJADHEY H,KESTERSON J,et al.Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity[J].Gastroenterology,2004,126 (5):1287-1292. 被引量：1
3CANNON C P,BRAUNWALD E,MCLABE C H,et al.Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators.intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350 (15):1495-1504. 被引量：1
